Association between antidepressant half-life and the risk of suicidal ideation or behavior among children and adolescents: Confirmatory analysis and research implications

被引:22
作者
Smith, Eric G. [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA
关键词
Antidepressants; Suicide attempt; Suicidal ideation; Half-life; Pharmacokinetics; Pediatric; RANDOMIZED CONTROLLED-TRIALS; FLUOXETINE; METAANALYSIS; DEPRESSION; SEROTONIN; EMERGENCE; SUNLIGHT; YOUTH; DRUGS; TADS;
D O I
10.1016/j.jad.2008.06.018
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: This study sought to determine from a recent meta-analysis of pediatric antidepressant trials if a general property of antidepressant medications - the multiple-dosing medication half-life - is associated with risks for suicidal ideation or behavior. Methods: Relative risks for suicidal behavior (ideation, attempt, or preparation) for seven antidepressants were obtained from both the FDA's initial and published versions of their pediatric antidepressant meta-analysis. The correlation between the relative risk for suicidal behavior and antidepressant half-life was examined using a nonparametric test, Spearman's rho. Results: A significant correlation (rho=0.929; p=0.003) was observed for the initial analysis, as previously reported by Weiss and Gorman. The correlation was robust to a change in the suicidality ranking for the longest half-life medication, fluoxetine, that occurred when results from the Treatment of Adolescent Depression Study (TADS) were included in the published meta-analysis (rho=0.786, p = 0.036). Limitations: In addition to limitations common to meta-analyses, our analysis has additional uncertainties including the fact that adult, rather than pediatric, antidepressant half-life data were used due to an unavailability of published information. In addition, risks for suicidal ideation/behavior may vary for reasons other than half-life (e.g. study eligibility criteria, illness severity or responsiveness to treatment, diagnoses, etc.). Conclusions: The risk of suicidal ideation or behavior in short-term antidepressant trials involving children or adolescents, as defined in the recent FDA meta-analysis, appears to be potentially at least partly associated with antidepressant half-life. Although any relationship is tentative, approaches to investigating several potential candidate mechanisms for any association are discussed. (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:143 / 148
页数:6
相关论文
共 25 条
  • [1] Mortality of patients with mood disorders: follow-up over 34-38 years
    Angst, F
    Stassen, HH
    Clayton, PJ
    Angst, J
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2002, 68 (2-3) : 167 - 181
  • [2] FLUOXETINE-INDUCED SUICIDALITY, SEROTONIN, AND SEASONALITY
    BREWERTON, TD
    [J]. BIOLOGICAL PSYCHIATRY, 1991, 30 (02) : 190 - 196
  • [3] Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment - A meta-analysis of randomized controlled trials
    Bridge, Jeffrey A.
    Iyengar, Satish
    Salary, Cheryl B.
    Barbe, Remy P.
    Birmaher, Boris
    Pincus, Harold Alan
    Ren, Lulu
    Brent, David A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (15): : 1683 - 1696
  • [4] Clinical pharmacokinetics of sertraline
    DeVane, CL
    Liston, HL
    Markowitz, JS
    [J]. CLINICAL PHARMACOKINETICS, 2002, 41 (15) : 1247 - 1266
  • [5] Treatment for Adolescents with Depression Study (TADS): Safety results
    Emslie, Graham
    Kratochvil, Christopher
    Vitiello, Benedetto
    Silva, Susan
    Mayes, Taryn
    McNulty, Steven
    Weller, Elizabeth
    Waslick, Bruce
    Casat, Charles
    Walkup, John
    Pathak, Sanjeev
    Rohde, Paul
    Posner, Kelly
    March, John
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (12) : 1440 - 1455
  • [6] The relevance of pharmacokinetic studies in designing efficacy trials in juvenile major depression
    Findling, RL
    McNamara, NK
    Stansbrey, RJ
    Feeny, NC
    Young, CM
    Peric, FV
    Youngstrom, EA
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (1-2) : 131 - 145
  • [7] Relationship between antidepressants and suicide attempts: An analysis of the veterans health administration data sets
    Gibbons, Robert D.
    Brown, C. Hendricks
    Hur, Kwan
    Marcus, Sue M.
    Bhaumik, Dulal K.
    Mann, J. John
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2007, 164 (07) : 1044 - 1049
  • [8] Selective serotonin reuptake inhibitors (SSR1s) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review
    Gunnell, D
    Saperia, J
    Ashby, D
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7488): : 385 - 388A
  • [9] Hammad T.A., 2004, RELATIONSHIP PSYCHOT
  • [10] Suicidality in pediatric patients treated with antidepressant drugs
    Hammad, TA
    Laughren, T
    Racoosin, J
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (03) : 332 - 339